Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | AZD4547 |
Trade Name | |
Synonyms | AZD-4547 |
Drug Descriptions |
AZD4547 selectively binds and inhibits FGFR1, 2, and 3, which may result in the inhibition of FGFR-mediated signal transduction pathways and inhibition of tumor cell proliferation (PMID: 22369928, PMID: 30115694, PMID: 32463741), and has demonstrated inhibitory effects on NTRK signaling (PMID: 34790577). |
DrugClasses | FGFR1 Inhibitor 28 FGFR2 Inhibitor 22 FGFR3 Inhibitor 19 |
CAS Registry Number | 1035270-39-3 |
NCIT ID | C88272 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABT-737 + AZD4547 | ABT-737 AZD4547 | 3 | 0 |
Alpelisib + AZD4547 + Osimertinib | AZD4547 Alpelisib Osimertinib | 0 | 0 |
Anastrozole + AZD4547 | AZD4547 Anastrozole | 0 | 0 |
AZD4547 | AZD4547 | 147 | 2 |
AZD4547 + AZD8055 | AZD4547 AZD8055 | 2 | 0 |
AZD4547 + Buparlisib | AZD4547 Buparlisib | 3 | 0 |
AZD4547 + Capivasertib | AZD4547 Capivasertib | 0 | 0 |
AZD4547 + Cisplatin + Gemcitabine | AZD4547 Cisplatin Gemcitabine | 0 | 0 |
AZD4547 + Crizotinib | AZD4547 Crizotinib | 0 | 0 |
AZD4547 + Durvalumab | AZD4547 Durvalumab | 0 | 1 |
AZD4547 + Fulvestrant | AZD4547 Fulvestrant | 1 | 0 |
AZD4547 + Gefitinib | AZD4547 Gefitinib | 0 | 0 |
AZD4547 + Lapatinib | AZD4547 Lapatinib | 0 | 0 |
AZD4547 + Letrozole | AZD4547 Letrozole | 0 | 0 |
AZD4547 + Osimertinib | AZD4547 Osimertinib | 0 | 0 |
AZD4547 + Pictilisib | AZD4547 Pictilisib | 1 | 0 |
AZD4547 + Sapanisertib | AZD4547 Sapanisertib | 0 | 0 |
AZD4547 + Sirolimus | AZD4547 Sirolimus | 2 | 0 |
AZD4547 + Trametinib | AZD4547 Trametinib | 0 | 0 |
AZD4547 + Vistusertib | AZD4547 Vistusertib | 3 | 0 |